topotecan has been researched along with axitinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Brooks, MM; Cammarata, PR; Neelam, S | 1 |
2 other study(ies) available for topotecan and axitinib
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.
Topics: Axitinib; Basic Helix-Loop-Helix Transcription Factors; Cell Hypoxia; Cell Line; Cell Survival; Epithelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Indazoles; Lens, Crystalline; MAP Kinase Signaling System; Models, Molecular; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Topotecan; Vascular Endothelial Growth Factor A | 2013 |